About Baxter International (NYSE:BAX)
Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.
Industry, Sector and Symbol
Industry MED PRODS
Sub-IndustryHealth Care Equipment
Trailing P/E Ratio49.8375956402763
Forward P/E Ratio23.13
Sales & Book Value
Annual Sales$10.56 billion
Price / Sales3.29
Cash Flow$3.85 per share
Price / Cash16.71
Book Value$16.73 per share
Price / Book3.84
Net Income$717 million
Return on Equity15.11%
Return on Assets8.18%
Baxter International (NYSE:BAX) Frequently Asked Questions
What is Baxter International's stock symbol?
Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."
How often does Baxter International pay dividends? What is the dividend yield for Baxter International?
Baxter International announced a quarterly dividend on Tuesday, February 20th. Shareholders of record on Friday, March 2nd will be paid a dividend of $0.16 per share on Monday, April 2nd. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date of this dividend is Thursday, March 1st. View Baxter International's Dividend History.
How will Baxter International's stock buyback program work?
Baxter International declared that its board has approved a share repurchase plan on Wednesday, February 21st 2018, which allows the company to repurchase $1,500,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's management believes its shares are undervalued.
How were Baxter International's earnings last quarter?
Baxter International Inc (NYSE:BAX) issued its quarterly earnings results on Thursday, February, 1st. The medical instruments supplier reported $0.64 EPS for the quarter, topping the Zacks' consensus estimate of $0.59 by $0.05. The medical instruments supplier earned $2.77 billion during the quarter, compared to analysts' expectations of $2.77 billion. Baxter International had a net margin of 6.79% and a return on equity of 15.11%. The company's revenue was up 4.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.57 EPS. View Baxter International's Earnings History.
When will Baxter International make its next earnings announcement?
What guidance has Baxter International issued on next quarter's earnings?
Baxter International issued an update on its FY18 earnings guidance on Thursday, February, 1st. The company provided EPS guidance of $2.72-2.80 for the period, compared to the Thomson Reuters consensus estimate of $2.72. The company issued revenue guidance of +6-7% (Approx $11.2-11.3 billion), compared to the consensus revenue estimate of $11.10 billion.Baxter International also updated its Q1 guidance to $0.60-0.62 EPS.
Where is Baxter International's stock going? Where will Baxter International's stock price be in 2018?
15 equities research analysts have issued 1 year price objectives for Baxter International's stock. Their predictions range from $62.00 to $80.00. On average, they anticipate Baxter International's stock price to reach $71.62 in the next twelve months. View Analyst Ratings for Baxter International.
Who are some of Baxter International's key competitors?
Some companies that are related to Baxter International include Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Fresenius Medical Care AG & Co. (FMS), McKesson (MCK), Essilor International (ESLOY), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), Sunny Optical Tech (SNPTF), Align Technology (ALGN), Cardinal Health (CAH), AmerisourceBergen (ABC), Lonza Group (LZAGY), IDEXX Laboratories (IDXX), Laboratory Corp. of America (LH), Smith & Nephew (SNN) and Coloplast A/S (CLPBY).
Who are Baxter International's key executives?
Baxter International's management team includes the folowing people:
- Jose E. Almeida, Chairman of the Board, President, Chief Executive Officer (Age 55)
- James K. Saccaro, Corporate Vice President and Chief Financial Officer (Age 44)
- Giuseppe Accogli, Senior Vice President, President - Global Businesses (Age 46)
- Brik V. Eyre, Senior Vice President, President - Americas (Age 53)
- Marcus Schabacker M.D. Ph.D., Chief Scientific Officer, Corporate Vice President (Age 53)
- Scott Pleau, Corporate Vice President - Operations (Age 51)
- Sean Martin, Corporate Vice President, General Counsel
- Jeanne K. Mason Ph.D., Corporate Vice President - Human Resources (Age 61)
- Paul Vibert, Corporate Vice President, President - International (Age 57)
- Thomas T. Stallkamp, Lead Independent Director (Age 70)
Has Baxter International been receiving favorable news coverage?
Press coverage about BAX stock has been trending positive recently, according to Accern. The research firm ranks the sentiment of media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Baxter International earned a daily sentiment score of 0.38 on Accern's scale. They also gave media coverage about the medical instruments supplier an impact score of 46.08 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.
Who are Baxter International's major shareholders?
Baxter International's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.69%), Geode Capital Management LLC (1.07%), Bank of New York Mellon Corp (0.91%), APG Asset Management N.V. (0.89%), Bessemer Group Inc. (0.69%) and Two Sigma Advisers LP (0.68%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Jose E Almeida, Peter S Hellman, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.
Which major investors are selling Baxter International stock?
BAX stock was sold by a variety of institutional investors in the last quarter, including Aristotle Capital Management LLC, BlackRock Inc., Thunderbird Partners LLP, Bessemer Group Inc., CI Global Investments Inc., First Trust Advisors LP, American Century Companies Inc. and Bank of Montreal Can. Company insiders that have sold Baxter International company stock in the last year include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.
Which major investors are buying Baxter International stock?
BAX stock was purchased by a variety of institutional investors in the last quarter, including Winslow Capital Management LLC, HealthCor Management L.P., Amundi Pioneer Asset Management Inc., Renaissance Technologies LLC, Old Mutual Global Investors UK Ltd., Acadian Asset Management LLC, Shell Asset Management Co. and Teacher Retirement System of Texas. View Insider Buying and Selling for Baxter International.
How do I buy shares of Baxter International?
Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Baxter International's stock price today?
One share of BAX stock can currently be purchased for approximately $64.29.
How big of a company is Baxter International?
Baxter International has a market capitalization of $35.41 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $1.29 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.
How can I contact Baxter International?
Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]
MarketBeat Community Rating for Baxter International (BAX)MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Baxter International (NYSE:BAX) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Buy||Buy|
|Consensus Rating Score: ||2.73||2.73||2.58||2.58|
|Ratings Breakdown: ||0 Sell Rating(s)|
5 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
|0 Sell Rating(s)|
5 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
|0 Sell Rating(s)|
6 Hold Rating(s)
5 Buy Rating(s)
1 Strong Buy Rating(s)
|1 Sell Rating(s)|
4 Hold Rating(s)
6 Buy Rating(s)
1 Strong Buy Rating(s)
|Consensus Price Target: ||$71.62||$71.62||$67.55||$65.73|
|Price Target Upside: ||11.39% upside||7.97% upside||5.47% upside||5.62% upside|
Baxter International (NYSE:BAX) Consensus Price Target History
Baxter International (NYSE:BAX) Analyst Ratings History
(Data available from 3/24/2016 forward)
Baxter International (NYSE:BAX) Earnings History and Estimates Chart
Baxter International (NYSE BAX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/1/2018||Q4 2017||$0.59||$0.64||$2.77 billion||$2.77 billion||View||Listen|
|10/25/2017||Q3 2017||$0.59||$0.64||$2.66 billion||$2.71 billion||View||N/A|
|7/26/2017||Q2 2017||$0.57||$0.63||$2.59 billion||$2.61 billion||View||N/A|
|4/26/2017||Q1 2017||$0.51||$0.58||$2.43 billion||$2.48 billion||View||N/A|
|2/1/2017||Q416||$0.52||$0.57||$2.65 billion||$2.65 billion||View||Listen|
|10/25/2016||Q316||$0.45||$0.56||$2.67 billion||$2.56 billion||View||Listen|
|7/26/2016||Q216||$0.40||$0.46||$2.51 billion||$2.60 billion||View||Listen|
|4/26/2016||Q116||$0.29||$0.36||$2.35 billion||$2.40 billion||View||Listen|
|2/2/2016||Q415||$0.32||$0.43||$2.55 billion||$2.60 billion||View||Listen|
|10/27/2015||Q315||$0.29||$0.41||$2.46 billion||$2.49 billion||View||Listen|
|7/29/2015||Q215||$0.94||$1.00||$2.40 billion||$3.90 billion||View||Listen|
|4/23/2015||Q115||$0.88||$1.00||$3.70 billion||$3.76 billion||View||Listen|
|1/29/2015||Q414||$1.31||$1.34||$4.37 billion||$4.47 billion||View||Listen|
|10/16/2014||Q314||$1.31||$1.31||$4.21 billion||$4.20 billion||View||Listen|
|7/17/2014||Q214||$1.21||$1.26||$4.12 billion||$4.30 billion||View||Listen|
|4/17/2014||Q114||$1.10||$1.19||$3.88 billion||$3.95 billion||View||Listen|
|1/23/2014||Q413||$1.25||$1.26||$4.25 billion||$4.40 billion||View||Listen|
|10/17/2013||Q313||$1.19||$1.19||$3.82 billion||$3.80 billion||View||Listen|
|7/18/2013||Q2 2013||$1.13||$1.16||$3.70 billion||$3.67 billion||View||Listen|
|4/18/2013||Q1 2013||$1.04||$1.05||$3.49 billion||$3.45 billion||View||Listen|
|1/24/2013||Q4 2012||$1.26||$1.26||$3.72 billion||$3.75 billion||View||Listen|
Baxter International (NYSE:BAX) Earnings Estimates
2018 EPS Consensus Estimate: $2.78
2019 EPS Consensus Estimate: $3.10
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Baxter International (NYSE:BAX) Dividend Information
|Dividend Growth:||-34.00% (3 Year Average)|
|Payout Ratio:||49.61% (Trailing 12 Months of Earnings) |
23.02% (Based on This Year's Estimates)
20.38% (Based on Next Year's Estimates)
Baxter International (NYSE:BAX) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Baxter International (NYSE BAX) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 0.05%
Institutional Ownership Percentage: 85.54%
Baxter International (NYSE BAX) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|3/2/2018||Carole J Shapazian||Director||Sell||4,990||$66.05||$329,589.50|| |
|1/2/2018||Giuseppe Accogli||SVP||Sell||28,641||$67.00||$1,918,947.00|| |
|12/4/2017||Jeanne K Mason||SVP||Sell||33,350||$65.25||$2,176,087.50||124,609|| |
|11/6/2017||Third Point Llc||Director||Sell||5,000,000||$64.23||$321,150,000.00|| |
|9/5/2017||Thomas T Stallkamp||Director||Sell||8,920||$62.28||$555,537.60||16,263|| |
|8/25/2017||John D Forsyth||Director||Sell||9,440||$61.76||$583,014.40||32,444|| |
|8/24/2017||Carole J Shapazian||Director||Sell||4,020||$61.61||$247,672.20||13,868|| |
|8/17/2017||Giuseppe Accogli||SVP||Sell||12,670||$60.96||$772,363.20||33,286|| |
|5/23/2017||Carole J Shapazian||Director||Sell||2,618||$57.92||$151,634.56||9,848|| |
|5/9/2017||Carole J Shapazian||Director||Sell||3,760||$55.89||$210,146.40||16,226|| |
|5/8/2017||Brik V Eyre||SVP||Sell||130,732||$55.69||$7,280,465.08||49,966|| |
|4/10/2017||Albert P L Stroucken||Director||Sell||4,280||$52.80||$225,984.00||25,667|| |
|3/29/2017||James R Gavin III||Director||Sell||4,280||$51.72||$221,361.60||34,980|| |
|2/22/2017||Peter S Hellman||Director||Sell||4,280||$49.81||$213,186.80||24,420|| |
|2/8/2017||John D Forsyth||Director||Sell||4,280||$48.35||$206,938.00||31,338|| |
|5/23/2016||Jose E Almeida||CEO||Buy||11,691||$42.75||$499,790.25||11,691|| |
|5/2/2016||John D Forsyth||Director||Sell||1,887||$44.38||$83,745.06||26,320|| |
|4/4/2016||John D Forsyth||Director||Sell||1,887||$41.75||$78,782.25||26,315|| |
|3/14/2016||James R Gavin III||Director||Sell||5,660||$40.34||$228,324.40||33,432|| |
|2/17/2016||Peter S. Hellman||Director||Sell||5,660||$38.35||$217,061.00||17,520|| |
|2/11/2016||Kornelis J. Storm||Director||Sell||5,660||$35.98||$203,646.80||19,191|| |
|5/22/2015||Carole J Shapazian||Director||Sell||1,533||$67.68||$103,753.44|| |
|4/27/2015||James R Gavin III||Director||Sell||4,830||$71.06||$343,219.80|| |
|7/25/2014||Carole J Shapazian||Director||Sell||1,645||$76.98||$126,632.10|| |
|7/24/2014||Thomas T Stallkamp||Director||Sell||8,300||$76.82||$637,606.00|| |
|7/9/2014||Ludwig Hantson||VP||Sell||24,693||$76.00||$1,876,668.00|| |
|5/2/2014||Carole Shapazian||Director||Sell||5,680||$75.28||$427,590.40||5,146|| |
|4/23/2014||Kees Storm||Director||Sell||5,760||$72.45||$417,312.00||15,156|| |
|4/21/2014||Blake Devitt||Director||Sell||4,334||$73.12||$316,902.08||16,541|| |
|3/27/2014||Sebastian Bufalino||VP||Sell||21,600||$75.10||$1,622,160.00||6,275|| |
|9/12/2013||Carole Shapazian||Director||Sell||1,941||$71.58||$138,936.78||5,111|| |
|8/1/2013||Robert L Parkinson Jr||CEO||Sell||725,750||$73.33||$53,219,247.50|| |
|7/26/2013||David P Scharf||VP||Sell||55,438||$73.79||$4,090,770.02|| |
|7/25/2013||James R Gavin III||Director||Sell||5,760||$72.82||$419,443.20|| |
|7/24/2013||Carole J Shapazian||Director||Sell||4,320||$73.58||$317,865.60|| |
|7/22/2013||Robert J Hombach||CFO||Sell||47,452||$73.95||$3,509,075.40|| |
|7/16/2013||Phillip L Batchelor||VP||Sell||5,850||$73.00||$427,050.00|| |
|5/22/2013||Blake E Devitt||Director||Sell||1,000||$72.34||$72,340.00|| |
|5/20/2013||Sebastian J Bufalino||VP||Sell||24,000||$73.75||$1,770,000.00|| |
|5/17/2013||Robert M Davis||VP||Sell||130,800||$73.00||$9,548,400.00|| |
|9/13/2012||Michael J Baughman||VP||Sell||11,500||$61.00||$701,500.00|| |
Baxter International (NYSE BAX) News Headlines
|Baxter International (BAX) Downgraded by Zacks Investment Research|
www.americanbankingnews.com - March 23 at 1:02 PM
|Baxter (BAX) Closes Acquisition of RECOTHROM & PREVELEAK - Nasdaq|
www.nasdaq.com - March 22 at 4:24 PM
|Baxter (BAX) Closes Acquisition of RECOTHROM & PREVELEAK|
www.zacks.com - March 22 at 9:42 AM
|Here's Why You Should Invest in Baxter International Now|
finance.yahoo.com - March 20 at 4:21 PM
|Baxter Completes Acquisition of RECOTHROM and PREVELEAK to ... - Business Wire (press release)|
www.businesswire.com - March 19 at 4:20 PM
|What Investors Should Know about TMO’s Dividends|
finance.yahoo.com - March 19 at 4:20 PM
|Baxter International (BAX) Lifted to "Buy" at Zacks Investment Research|
www.americanbankingnews.com - March 19 at 11:15 AM
| Analysts Expect Baxter International Inc (BAX) Will Announce Quarterly Sales of $2.62 Billion|
www.americanbankingnews.com - March 18 at 10:43 AM
|Critical Survey: Utah Medical Products (UTMD) versus Baxter International (BAX)|
www.americanbankingnews.com - March 16 at 11:12 PM
| Brokerages Anticipate Baxter International Inc (BAX) Will Post Earnings of $0.62 Per Share|
www.americanbankingnews.com - March 16 at 11:33 AM
|Global Antiemetic Market Opportunities 2018: Astellas Pharma, Novartis AG, , Baxter International|
www.marketwatch.com - March 12 at 4:17 PM
|Baxter International Inc (BAX) Receives Consensus Recommendation of "Buy" from Analysts|
www.americanbankingnews.com - March 10 at 9:44 AM
|See what the IHS Markit Score report has to say about Baxter International Inc.|
finance.yahoo.com - March 9 at 11:36 AM
|Baxter (BAX) Presents At Raymond James 39th Annual Institutional Investors Conference - Slideshow|
seekingalpha.com - March 8 at 11:02 AM
|What’s Stryker’s Guidance for 2018 and Beyond?|
finance.yahoo.com - March 6 at 4:14 PM
|Baxter International Inc (BAX) Shares Bought by Koch Industries Inc.|
www.americanbankingnews.com - March 6 at 2:03 PM
|Carole J. Shapazian Sells 4,990 Shares of Baxter International Inc (BAX) Stock|
www.americanbankingnews.com - March 5 at 7:00 PM
|Moors & Cabot Inc. Has $3.65 Million Stake in Baxter International Inc (BAX)|
www.americanbankingnews.com - March 5 at 3:44 PM
|Baxter International Inc (BAX) Holdings Trimmed by Corient Capital Partners LLC|
www.americanbankingnews.com - March 5 at 11:56 AM
|Lombard Odier Asset Management Switzerland SA Grows Holdings in Baxter International Inc (BAX)|
www.americanbankingnews.com - March 5 at 11:56 AM
|Mackenzie Financial Corp Boosts Position in Baxter International Inc (BAX)|
www.americanbankingnews.com - March 5 at 11:07 AM
|Baxter International Inc (BAX) Stake Lessened by USA Financial Portformulas Corp|
www.americanbankingnews.com - March 4 at 2:49 PM
|Baxter International Inc (BAX) Stake Increased by Geode Capital Management LLC|
www.americanbankingnews.com - March 4 at 1:48 PM
|Baxter International Inc (BAX) Position Boosted by Maverick Capital Ltd.|
www.americanbankingnews.com - March 3 at 1:48 PM
|Haverford Trust Co. Has $71.50 Million Position in Baxter International Inc (BAX)|
www.americanbankingnews.com - March 2 at 5:16 PM
|Baxter International Inc. (BAX) Ex-Dividend Date Scheduled for March 01, 2018 - Nasdaq|
www.nasdaq.com - March 2 at 4:13 PM
|Commerce Bank Sells 2,728 Shares of Baxter International Inc (BAX)|
www.americanbankingnews.com - March 2 at 1:04 PM
|First Trust Advisors LP Cuts Holdings in Baxter International Inc (BAX)|
www.americanbankingnews.com - March 2 at 8:18 AM
|Amalgamated Bank Grows Position in Baxter International Inc (BAX)|
www.americanbankingnews.com - March 2 at 4:20 AM
|Dorsey & Whitney Trust CO LLC Reduces Holdings in Baxter International Inc (BAX)|
www.americanbankingnews.com - March 1 at 3:48 PM
|$2.62 Billion in Sales Expected for Baxter International Inc (BAX) This Quarter|
www.americanbankingnews.com - March 1 at 10:50 AM
|Calamos Advisors LLC Grows Holdings in Baxter International Inc (BAX)|
www.americanbankingnews.com - March 1 at 5:28 AM
|Baxter International Inc (BAX) Holdings Reduced by Lipe & Dalton|
www.americanbankingnews.com - February 28 at 3:24 PM
|Calamos Wealth Management LLC Sells 1,322 Shares of Baxter International Inc (BAX)|
www.americanbankingnews.com - February 28 at 5:22 AM
|Baxter International Inc (BAX) Stake Lifted by First Republic Investment Management Inc.|
www.americanbankingnews.com - February 27 at 12:44 PM
|$0.62 Earnings Per Share Expected for Baxter International Inc (BAX) This Quarter|
www.americanbankingnews.com - February 27 at 12:04 PM
|Baxter International Inc (BAX) Shares Bought by Financial Counselors Inc.|
www.americanbankingnews.com - February 26 at 3:08 PM
|Quadrature Capital Ltd Acquires Shares of 28,054 Baxter International Inc (BAX)|
www.americanbankingnews.com - February 26 at 2:48 PM
|Baxter International Inc (BAX) Shares Bought by Eaton Vance Management|
www.americanbankingnews.com - February 26 at 2:38 PM
|Winslow Capital Management LLC Invests $178.65 Million in Baxter International Inc (BAX) Stock|
www.americanbankingnews.com - February 26 at 1:10 PM
|Want To Invest In Baxter International Inc (NYSE:BAX)? Here’s How It Performed Lately|
finance.yahoo.com - February 26 at 9:59 AM
|Baxter International Inc (BAX) Shares Bought by Baird Financial Group Inc.|
www.americanbankingnews.com - February 25 at 4:26 AM
|Raymond James Financial Services Advisors Inc. Sells 1,975 Shares of Baxter International Inc (BAX)|
www.americanbankingnews.com - February 24 at 8:30 AM
|Abbott Laboratories’ Stock Performance after a Recent Bull Run|
finance.yahoo.com - February 23 at 10:04 AM
|Baxter International Inc (BAX) Files 10-K for the Fiscal Year Ended on December 31, 2017|
finance.yahoo.com - February 23 at 10:04 AM
|Active-Investors: Free Post Earnings Research Report: Baxter's Quarterly Sales Grew 5%; Adjusted EPS Advanced 12%|
www.finanznachrichten.de - February 22 at 9:45 AM
|Reviewing Baxter International (BAX) and Zimmer Biomet (ZBH)|
www.americanbankingnews.com - February 22 at 3:16 AM
|Baxter International (BAX) to Repurchase $1.50 billion in Shares|
www.americanbankingnews.com - February 21 at 11:24 AM
|Baxter International Inc Plans Quarterly Dividend of $0.16 (BAX)|
www.americanbankingnews.com - February 21 at 9:57 AM
|Baxter International (BAX) Stock Rating Upgraded by Deutsche Bank|
www.americanbankingnews.com - February 20 at 10:08 PM
Baxter International (NYSE:BAX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Baxter International (NYSE:BAX) Income Statement, Balance Sheet and Cash Flow Statement
Baxter International (NYSE BAX) Stock Chart for Saturday, March, 24, 2018